BLOOD CANCER DISCOVERY : Impact Factor & More
eISSN: 2643-3249pISSN: 2643-3230
Share this on:
Key Metrics
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on BLOOD CANCER DISCOVERY
BLOOD CANCER DISCOVERY Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | AMER ASSOC CANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2020 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in BLOOD CANCER DISCOVERY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in BLOOD CANCER DISCOVERY
MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia.
- 1 Jul 2026
- Blood cancer discovery
KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid Malignancies.
- 1 Jul 2026
- Blood cancer discovery
New Insights into the Role of Clonotypic B Cells in Plasma-cell Neoplasia.
- 1 Jul 2026
- Blood cancer discovery
Understanding the Molecular Mechanisms Underlying Anemia in Myelodysplastic Syndromes: From Erythropoiesis to New Therapeutic Approaches.
- 1 Jul 2026
- Blood cancer discovery
Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.
- 1 Jul 2026
- Blood cancer discovery
Rapid Transcription Dynamics Confers Cytarabine Resistance in Acute Myeloid Leukemia.
- 1 Jul 2026
- Blood cancer discovery
MYST Acetyltransferases Interact with SETBP1 and Are a Targetable Therapeutic Vulnerability in SETBP1-Mutant Leukemia.
- 1 Jul 2026
- Blood cancer discovery
KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid Malignancies.
- 1 Jul 2026
- Blood cancer discovery
New Insights into the Role of Clonotypic B Cells in Plasma-cell Neoplasia.
- 1 Jul 2026
- Blood cancer discovery
Understanding the Molecular Mechanisms Underlying Anemia in Myelodysplastic Syndromes: From Erythropoiesis to New Therapeutic Approaches.
- 1 Jul 2026
- Blood cancer discovery
Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell Lymphoma.
- 1 Jul 2026
- Blood cancer discovery
Rapid Transcription Dynamics Confers Cytarabine Resistance in Acute Myeloid Leukemia.
- 1 Jul 2026
- Blood cancer discovery
FAQs on BLOOD CANCER DISCOVERY
How long has BLOOD CANCER DISCOVERY been actively publishing? 
What is the publishing frequency of BLOOD CANCER DISCOVERY?
How many articles did BLOOD CANCER DISCOVERY publish last year?
What is the eISSN & pISSN for BLOOD CANCER DISCOVERY?
Who is the publisher of BLOOD CANCER DISCOVERY?
